Why a complete list matters
Medication reconciliation aims to create the most complete and accurate list of current medicines and compare that list with the record or current orders. [1] The process is intended to identify and prevent omissions, duplications, dose or timing errors, and interactions. [1]
A comprehensive history includes prescription medicines, over-the-counter products, herbals, vitamins, and supplements—not just the products that feel most important. [1] Name, dose, route, and frequency are among the core medication-history details. [1] FDA consumer guidance says to update a medication list after a new prescription, a dosage change, or stopping a medicine, and to keep and share a copy. [2]
The three-layer handoff
Layer 1 · what is current
One-page snapshot
Make this the fast, current view. For each item, copy what the label and record say: [1] [2] [3]
- Exact label or product name; active ingredient if shown
- Why it was prescribed or used
- Prescriber, pharmacy, or source
- Current clinician-directed instructions as written
- Route and frequency
- Current, stopped, or paused status
- Start and stop dates, if known
- Lot or expiration, when available
- All prescriptions, OTC products, vitamins, herbals, and supplements [1]
- Allergies exactly as documented
Copy, don’t calculate. Name, dose, route, and frequency are established medication-history fields. [1]
Layer 2 · what happened when
Dated change and event log
Keep each event neutral and time-stamped. Record context without assigning cause: [3]
- Date and time
- What actually happened
- The prescribed plan at that time
- What changed and who directed the change
- Symptom onset or offset in plain, neutral language
- Relevant measurement or lab copied with its date, units, and source
- Other products used at the same time
Write “headache began 6:30 p.m.” rather than deciding what caused it. The log preserves sequence; it does not establish causality. FDA Form 3500 instructions provide a useful field-design reference for dated products, events, tests, and concurrent products; this worksheet does not imply that everyone should file that form. [3]
Layer 3 · what remains unresolved
Discrepancies and questions
Keep a separate queue for details that conflict across the product label, personal list or app, pharmacy or clinical record, and after-visit summary. Preserve both versions, name each source, and mark the item unresolved for prescriber or pharmacist review. This is an organizational framework—not a clinical conclusion about which version is correct.
A copy-ready prescriber handoff worksheet
Copy these headings into a document or print the tables. Enter only what the label, record, or other named source says. Blank and unresolved are valid states; this worksheet organizes evidence for a conversation and does not reconcile it clinically.
| Field | Copy from the source | Source / evidence |
|---|---|---|
| Product identity | Exact product/name; strength or concentration as labeled; purpose | Label, medication list, pharmacy, or record [1] [2] |
| Clinician-directed plan | Instructions copied as written; route; frequency | Label or current clinical record [1] [2] |
| Source and status | Prescriber, pharmacy, or other source; current status; start and stop dates if known | Named source and date checked [2] [3] |
| Traceable details | Manufacturer or compounder; NDC or unique ID; lot; expiration, when available | Packaging or dispensing record [3] |
| Complete list | Prescriptions, OTC products, vitamins, herbals, and supplements | All current sources [1] [2] |
| Allergies | Copy exactly as documented | Medication list or clinical record [2] |
| Timestamp | Product | Actual event | Documented plan | Directed change + who directed it | Neutral symptom / event wording | Measurement / lab | Other products at the time |
|---|---|---|---|---|---|---|---|
| Date + time | Exact name | What occurred | Copy as written | Change + named source | Observed sequence, no cause assigned | Value + date + unit + source | Names used concurrently |
These product, treatment-date, event, test, and concurrent-product fields are adapted from FDA Form 3500 instructions as a field-design reference; using this worksheet does not mean a Form 3500 report is required. [3]
| Field in conflict | Version A + source | Version B + source | Status / question |
|---|---|---|---|
| Name, strength, instructions, status, or date | Label, app/list, pharmacy/record, or after-visit summary | Preserve the conflicting version and its source | Unresolved — for prescriber or pharmacist review |
Preserving both versions and marking the conflict unresolved is this worksheet’s organizational framework. It does not decide which record is clinically correct.
Why name every product
Current product labels show why exact names and the full medication list matter. These are examples, not an interaction screen, and they do not determine what is safe for an individual. The applicable label and prescriber own those decisions.
| Label example | What it says | Why it belongs in the handoff |
|---|---|---|
| Wegovy and overlapping products | Concomitant use with other semaglutide-containing products or another GLP-1 receptor agonist is not recommended. [4] | This is why exact product and active-ingredient names belong in the handoff. |
| Wegovy or Zepbound and oral medicines | Both labels say the product delays gastric emptying and may affect absorption of concomitant oral medicines. [4] [5] | This is why oral medicines belong in the same handoff. |
| Wegovy or Zepbound with insulin or an insulin secretagogue | Both labels describe increased hypoglycemia risk with insulin or an insulin secretagogue. [4] [5] | This is why concurrent medicines should be named for prescriber review. |
Five-minute reconciliation before the visit
This is a record-preparation workflow: medication reconciliation compares a complete current list with records or orders, while FDA guidance supports keeping the list updated and sharing a copy. [1] [2]
- 1. Compare the sources. Place the app or personal list beside labels, the pharmacy or clinical record, and the latest after-visit summary.
- 2. Mark exact conflicts. Copy the competing names, strengths, instructions, statuses, or dates and identify each source.
- 3. Update only verified facts. Change the current snapshot when the new fact and its source are clear.
- 4. Keep unresolved items visible. Preserve both versions in the discrepancy queue without deciding which is correct.
- 5. Bring the top questions. Use the queue to make the unresolved points easy for the prescriber or pharmacist to review.
What this record cannot tell you
It cannot establish what caused a symptom or result.
It cannot clear a combination for interactions.
It cannot select a dose, timing, or schedule.
It cannot interpret a lab value or trend.
It cannot prove a product’s identity or purity.
Questions for the prescriber
- Which item on this list needs special monitoring?
- Are any names on this list duplicates or overlaps?
- Which change in the dated log matters most?
- What should count as a reason to contact the office?
- What should this record show before the next follow-up?
Keep the three layers together
Build a legible protocol history
Jabbit can organize a clinician-directed schedule with smart scheduling, vial tracking, injection and site history, reminders, and progress tracking. [6] Jabbit is a personal tracking tool, not a medical device, and does not provide medical advice, diagnosis, or treatment.
Track your clinician-directed plan in JabbitFrequently asked questions
What should be in a prescriber handoff?
Use three layers: a current snapshot with exact product details, a dated log of what happened and changed, and an unresolved discrepancy and question list. Include prescriptions, over-the-counter products, vitamins, herbals, and supplements. [1]
Should supplements and over-the-counter products be included?
Yes. A comprehensive medication history includes over-the-counter products, herbals, vitamins, and supplements along with prescription medicines. [1]
Does this handoff check interactions?
No. This handoff organizes names, schedules, history, and symptom timing; it does not screen interactions or determine whether a combination is safe. Those decisions belong to the prescriber using the applicable labels and individual clinical context.
How should conflicting records be handled in the handoff?
Preserve both versions, identify their sources, and mark the conflict unresolved for prescriber or pharmacist review. The discrepancy list organizes the question; it is not a clinical conclusion.
Sources opened and checked
- [1]AHRQ Patient Safety and Quality: Medication Reconciliation.
- [2]FDA: Create and Keep a Medication List for Your Health.
- [3]FDA: Instructions for Completing Form FDA 3500.
- [4]Current Wegovy labeling, DailyMed.
- [5]Current Zepbound labeling, DailyMed.
- [6]Jabbit on the Apple App Store — apps.apple.com/app/id6756848719.
All six sources were opened and checked on August 14, 2026.